About 30% of patients with cirrhosis have diabetes mellitus (DM). Nowadays, it is a matter for
debate whether type 2 DM in the absence of obesity and hypertriglyceridemia may be a risk …

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide. Much of the recognised health-care burden occurs in the minority of people with …

Objective Chronic liver disease (CLD) is a major cause of mortality and morbidity worldwide.
The aim of this study was to assess the overall and liver-related mortality and their predictors …

OBJECTIVE To describe associations between alcoholic liver disease (ALD) or nonalcoholic
fatty liver disease (NAFLD) hospital admission and cardiovascular disease (CVD), cancer …

Bile acids act as signaling molecules and stimulate the G protein coupled receptor, TGR5, in
addition to nuclear farnesoid X receptor to regulate lipid, glucose and energy metabolism …

ETHNOPHARMACOLOGICAL RELEVANCE: The seed of Entada phaseoloides (L.)
Merr.(Entada phaseoloides) has been long used as an effective herb for the treatment of …

Balancing basic science with information on everyday clinical practice, Blumgart's Surgery of
the Liver, Biliary Tract and Pancreas, 7th Edition, provides you with expert guidance and …

BACKGROUND & AIMS: With the limited efficacy of current therapy for chronic hepatitis C,
modifiable risk factors for liver disease progression are important to identify. Because …

Diabetes developed as a complication of cirrhosis is known as «hepatogenous
diabetes»(HD). Around 30% to 60% of cirrhotic patients suffer from this metabolic disorder …

OBJECTIVES: As most hepatocellular carcinoma (HCC) patients have cirrhosis, the
association between diabetes and HCC may be confounded by the fact that diabetes is …